HUMANER ANTI-IGG1-ANTIKÖRPER

European patent · EP2606071 · In force

Register entry

Publication number
EP2606071
Application number
EP11743069
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 12, 2011
Published
Jun 26, 2013
Granted
Dec 18, 2019
Protection ends at the latest
Aug 11, 2031
Next annual fee due
Aug 31, 2027
IPC classes
C07K 16/42 (2006.01)
G01N 33/68 (2006.01)
Priority
EP 10173090 17.08.2010
PCT application
PCT/EP2011/063906 12.08.2011
PCT publication
WO2012/022682 23.02.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  6. Dec 18, 2019

    Granted

    Published in Swissreg on 18.12.2019

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

STUBENRAUCH, Kay-Gunnar

82377 Penzberg, DE

ESSIG, Ulrich

82152 Planegg, DE

KOWALEWSKY, Frank

81479 Muenchen, DE

KLOSTERMANN, Stefan

82061 Neuried, DE

VOGEL, Rudolf

82362 Weilheim, DE

WESSELS, Uwe

82377 Penzberg, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.